Southampton scientists make breakthrough that could help patients with mesothelioma survive longer

Scientists based at the Centre for Cancer Immunology have made a breakthrough with immunotherapy that could help patients with a hard-to-treat cancer caused by asbestos.


Intensive combination chemotherapy and immunotherapy can improve survival for some patients with rare blood cancer

An international trial, run in the UK by researchers at the CRUK Southampton Clinical Trials Unit (SCTU) at the Centre for Cancer Immunology, has found that an intensive combination of chemotherapy and immunotherapy can dramatically improve survival for some patients with a rare blood cancer that typically have a very poor outlook.


Understanding how to improve antibodies targeting OX40 for the treatment of cancer

Understanding how to improve antibodies targeting OX40 for the treatment of cancer


£10 million research collaboration to detect lung cancer earlier

Professor Peter Johnson of the Centre for Cancer Immunology is to lead a ground-breaking project, which will explore new ways to diagnose lung cancer earlier and save lives.


Exciting trial results from the Centre for Cancer Immunology expected in 2021

Despite a challenging 2020, researchers from the Centre for Cancer Immunology are set to announce exciting trial results in the new year, as well as push their current immunology research programmes forward.


Pioneering immunologist recognised for life’s work

World-leading immunologist, Professor Freda Stevenson from the Centre of Cancer Immunology, has been awarded a Lifetime Achievement Award from the British Society of Haematology.


Southampton cancer scientists discover new checkpoint to use in immunotherapy

Researchers at the Centre for Cancer Immunology have shed new light on a key part of the immune system that could pave the way for more targeted treatments in fighting cancer.


International project seeks to improve cancer-fighting therapeutics

Scientists at the Centre for Cancer Immunology have begun a new collaborative study to understand how therapeutic antibodies stimulate the body’s immune cells to kill other cells that contribute to a wide range of diseases, including cancer.


Positive topline trial results using antibody designed by Centre scientist

An engineered antibody, designed by a scientist now based at the Centre for Cancer Immunology, has shown it could help treat people with severe autoimmune diseases and also in the diagnostic imaging of cancer.


Centre Director to lead new British Society for Immunology journal

Professor Tim Elliott, Director of the Centre for Cancer Immunology, has been appointed as Founding Editor-In-Chief of the new journal Immunotherapy Advances.